CPHI Barcelona 2023 award winners announced at buzzing ceremony

2023-10-26

With a packed room full of excitement and anticipation, guests were treated to live music, a range of delicious food and a hoola-hoop dancing display.

The awards recognize outstanding achievements and contributions from the global pharma industry and supply chain across 12 wide-ranging categories.

Enrico Zodio, CEO of Procos, stood out as the clear winner in one of the most coveted prizes – CEO of the Year – for spearheading the company’s impressive development and growth. Procos now turns over more than €200 million, having invested in capacity to further increase production, it is among an elite class of CDMOs globally.

In the API Development category, Snapdragon Chemistry, a Cambrex company, was selected as the winner for the development of an ultra-high temperature - more than 300 °C - continuous flow manufacturing process for racemization of sotorsib (LUMAKRASTM) P-dione.

For the finished Formulation, the judges selected Lubrizol Life Science Health for the development and launch of the first solubility-enhancing excipient to be specifically designed for parenteral use in over 20 years.

A manufacturing platform, developed by Luminary Therapeutics, that aims to bring allogeneic cell therapies into the marketplace for under $10,000 was the stand-out entry in the Manufacturing Excellence category.

Gasporox took the honors in the Packaging & Machinery section for its AutoMAP™ Pharma gas measurement system for high or low concentrations of O2 in modified atmosphere packaging.

googletag.cmd.push(function () {

googletag.display('text-ad1');

});

In the Supply Chain Excellence category, Catalent came out top for its outstanding Case Management Services, which provides end-to-end professional supply chain management and orchestration for autologous and allogeneic cell and gene therapies.

A comprehensive EDC solution from Lambda Therapeutic Research, that enhances research efficiency and streamlines data management was selected as a beacon of Regulatory Compliance.

In the Drug Delivery & Device Innovation category, the judges were full of praise for Medicsen’s SMARTPATCH - a wearable patch that uses ultrasounds to deliver drugs subcutaneously, avoiding needles and cannulas to create a unique drug delivery system that ensures patient comfort.

Representing Accelerating Innovation React4Life’s MIVO (Multi In Vitro Organ) patented organ-on-a-chip was another clear winner. This can host and culture 3D human biological cells or tissues under fluid dynamic conditions as in vivo, overcoming the limitations of current pre-clinical assays while reducing animal testing.

Schneider Electric was the winner for Sustainability thanks to its Energize program that enables collaboration between 18 global pharmaceutical companies to collectively engage hundreds of suppliers in bold climate action and decarbonization of the pharmaceutical value chain.

InSyBio impressed the judges reviewing the brand-new Start-Up Initiative category for its ability to revolutionize the medical ﬁeld, clinical trials, and food/nutrition industries through its targeted biomarker discovery.

Another new category was added this year to celebrate our own CPHI ethos, the ‘Heart of Pharma’ award. The inaugural winners were Merck KGaA – chosen for its Embracing Carers initiative. An inspiring carer-centric initiation it aims to recognize the role that family carers play in society and support them at each step in their caregiving journey.

Tara Dougal, content director for Pharma at Informa Markets “CPHI aims to position itself at the ‘heart of pharma’ by creating an environment where everyone in our industry can come together to exchange ideas and build productive new alliances for the ultimate benefit of patients.

“I wholeheartedly congratulate all winners of this 20th edition of the CPHI Pharma Awards. Those committed to driving innovation across the key disciplines that shape the success of our industry.

“I’d also like to thank all those who submitted an entry this year, and the members of our jury who so diligently reviewed them.”